mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.11 |
0.05 |
mRNA |
QW-BI-011 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.06 |
mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.06 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.06 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.06 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.06 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.06 |
mRNA |
vorapaxar |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.06 |
mRNA |
SZ4TA2 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.07 |
mRNA |
TGX221 |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.07 |